The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

NCT06707402 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2025-07-03

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that is most effective. The main questions are:

If brisk walking can reduce self-perceived walking difficulty What type of exercise intervention is most effective. Researchers will compare a brisk walking group receiving a personalized walking program with a group receiving an activity tracker and a control group.

Participants will

* be tested at baseline (0 weeks), post the intervention period (24 weeks) and after a follow-up period (48 weeks).
* be randomly allocated to one of three groups at baseline.
* follow the prescribed intervention they are allocated to.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

WALK

The intervention covers a personalized 24-week progressive brisk walking program. The program consists of moderate to high-intensity walking (i.e., 55-85% maximal heart rate) performed as both continuous and interval training sessions 2-3 times/week lasting 30-60 min/session. Four individually supervised sessions will be conducted in the first 2 weeks, while 1 supervised group session will be received bi-weekly. Furthermore, the group will receive an activity tracker and monthly telephone calls will be offered to adjust the intensity of the program (if necessary), clarify any questions regarding the intervention, and give verbal motivation. At the baseline assessment and at week 12, during a group training session, the figure of 8 walk test will be conducted to gain insigh tinto the current status of the training program. Lastly, after completion of the baseline test, the participants are given a brief educational session (walking advice) on recommended guidelines for physical activity

BEHAVIORAL

ACTIVE

Will receive an activity tracker is provided alongside monthly telephone calls and walking advice after the baseline test. Similar to WALK, 3 telephone calls are provided during the follow-up period.

BEHAVIORAL

CON

Receives a brief educational session (walking advice) is provided at baseline, after which no further contacts are made.

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER
  • Viborg Regional Hospital

    collaborator OTHER
  • Danish Parkinson Association

    collaborator OTHER
  • Fonden af 2. Juli 1984 til bekæmpelse af Parkinsons Sygdom, Denmark

    collaborator UNKNOWN
  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-11
Primary Completion
2027-08-01
Completion
2027-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06707402 on ClinicalTrials.gov